| Breast cancer: Biology, biomarkers, and treatments K Barzaman, J Karami, Z Zarei, A Hosseinzadeh, MH Kazemi, ... International immunopharmacology 84, 106535, 2020 | 536 | 2020 |
| Potential role of interferons in treating COVID-19 patients MH Abdolvahab, S Moradi-Kalbolandi, M Zarei, D Bose, K Majidzadeh-A, ... International immunopharmacology 90, 107171, 2021 | 78 | 2021 |
| Breast cancer immunotherapy: Current and novel approaches K Barzaman, S Moradi-Kalbolandi, A Hosseinzadeh, MH Kazemi, ... International immunopharmacology 98, 107886, 2021 | 64 | 2021 |
| Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER S Moradi-Kalbolandi, A Hosseinzade, M Salehi, P Merikhian, ... Journal of Pharmacy and Pharmacology 70 (7), 841-854, 2018 | 39 | 2018 |
| The role of mucosal immunity and recombinant probiotics in SARS-CoV2 vaccine development S Moradi-Kalbolandi, K Majidzadeh-A, MH Abdolvahab, N Jalili, ... Probiotics and antimicrobial proteins, 1-15, 2021 | 29 | 2021 |
| Development of anti-CD47 single-chain variable fragment targeted magnetic nanoparticles for treatment of human bladder cancer G Rezaei, M Habibi-Anbouhi, M Mahmoudi, K Azadmanesh, ... Nanomedicine 12 (6), 597-613, 2017 | 23 | 2017 |
| Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk K Barzaman, R Vafaei, M Samadi, MH Kazemi, A Hosseinzadeh, ... Cancer Cell International 22 (1), 259, 2022 | 17 | 2022 |
| Evaluation the potential of recombinant anti-CD3 nanobody on immunomodulatory function S Moradi-Kalbolandi, A Sharifi-K, B Darvishi, K Majidzadeh-A, S Sadeghi, ... Molecular immunology 118, 174-181, 2020 | 15 | 2020 |
| Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo M Samadi, K Majidzadeh-A, M Salehi, N Jalili, Z Noorinejad, ... Journal of Biological Engineering 15, 1-15, 2021 | 14 | 2021 |
| Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors P Merikhian, B Darvishi, N Jalili, MR Esmailinejad, AS Khatibi, ... Molecular oncology 16 (2), 485-507, 2022 | 13 | 2022 |
| Soluble expression and characterization of a new scFv directed to human CD123 S Moradi-Kalbolandi, D Davani, M Golkar, M Habibi-Anbouhi, ... Applied biochemistry and biotechnology 178, 1390-1406, 2016 | 12 | 2016 |
| Antigenic assessment of a recombinant human CD90 protein expressed in prokaryotic expression system N Yousefi-Rad, MA Shokrgozar, M Behdani, S Moradi-Kalbolandi, ... Protein Expression and Purification 116, 139-143, 2015 | 11 | 2015 |
| Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency K Barzaman, M Samadi, S Moradi-Kalbolandi, K Majidzadeh-A, M Salehi, ... Experimental Cell Research 405 (2), 112685, 2021 | 10 | 2021 |
| Dual in vitro invasion/migration suppressing and tamoxifen response modulating effects of a recombinant anti‐ALCAM scFv on breast cancer cells B Darvishi, M Salehi, S Boroumandieh, K Majidzadeh‐A, N Jalili, ... Cell Biochemistry and Function 38 (5), 651-659, 2020 | 10 | 2020 |
| Development of a novel engineered antibody targeting human CD123 S Moradi-Kalbolandi, M Habibi-Anbouhi, M Golkar, M Behdani, G Rezaei, ... Analytical biochemistry 511, 27-30, 2016 | 10 | 2016 |
| Development of an anti-CD45RA-quantum dots conjugated scFv to detect leukemic cancer stem cells S Moradi-Kalbolandi, F Dashtestani, M Salehi, N Jalili, K Majidzadeh-A, ... Molecular Biology Reports 47, 225-234, 2020 | 7 | 2020 |
| Enhancement of extracellular bispecific anti‐MUC1 nanobody expression in E. coli BL21 (DE3) by optimization of temperature and carbon sources through an … L Rezaei, SA Shojaosadati, L Farahmand, S Moradi‐Kalbolandi Engineering in life sciences 20 (8), 338-349, 2020 | 5 | 2020 |
| Improvement of cytotoxicity and necrosis activity of ganoderic acid a through the development of PMBN-A. Her2-GA as a targeted nano system PM Fath, M Rahimnejad, S Moradi-Kalbolandi, BE Hosseinzadeh, ... RSC advances 12 (2), 1228-1237, 2022 | 3 | 2022 |
| Anti-MUC1 nanobody conjugated by chitosan nanoparticle with enhancement of anti-proliferation activity in breast cancer cell lines F Khodabakhsh, S Shokri, N Jalili, S Moradi-Kalbolandi, F Dashtestani, ... Chemical Papers 77 (4), 2229-2235, 2023 | 2 | 2023 |
| Development of a MET-targeted single-chain antibody fragment as an anti-oncogene targeted therapy for breast cancer R Vafaei, Z Khaki, M Salehi, N Jalili, MR Esmailinejad, ... Investigational New Drugs 41 (2), 226-239, 2023 | 2 | 2023 |
